Cargando…
Intestinal fatty acid binding protein is a disease biomarker in paediatric coeliac disease and Crohn’s disease
BACKGROUND: There is a clinical need to develop biomarkers of small bowel damage in coeliac disease and Crohn’s disease. This study evaluated intestinal fatty acid binding protein (iFABP), a potential biomarker of small bowel damage, in children with coeliac disease and Crohn’s disease. METHODS: The...
Autores principales: | Logan, Michael, MacKinder, Mary, Clark, Clare Martha, Kountouri, Aikaterini, Jere, Mwansa, Ijaz, Umer Zeeshan, Hansen, Richard, McGrogan, Paraic, Russell, Richard K., Gerasimidis, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125891/ https://www.ncbi.nlm.nih.gov/pubmed/35606704 http://dx.doi.org/10.1186/s12876-022-02334-6 |
Ejemplares similares
-
Nutritional status, growth and disease management in children with single and dual diagnosis of type 1 diabetes mellitus and coeliac disease
por: Mackinder, Mary, et al.
Publicado: (2014) -
The distinct features of microbial ‘dysbiosis’ of Crohn’s disease do not occur to the same extent in their unaffected, genetically-linked kindred
por: Ijaz, Umer Zeeshan, et al.
Publicado: (2017) -
Extensive Modulation of the Fecal Metagenome in Children With Crohn's Disease During Exclusive Enteral Nutrition
por: Quince, Christopher, et al.
Publicado: (2015) -
Alterations in Intestinal Microbiota of Children With Celiac Disease at the Time of Diagnosis and on a Gluten-free Diet
por: Zafeiropoulou, Konstantina, et al.
Publicado: (2020) -
Point-of-care faecal calprotectin testing in patients with paediatric inflammatory bowel disease during the COVID-19 pandemic
por: Jere, Mwansa, et al.
Publicado: (2021)